Publications by authors named "Jean Bergeron"

Claim this Profile
Z
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial.
Frederick J Raal, Jean Bergeron, Daniel Gaudet, Robert S Rosenson, David R Sullivan

Lancet Diabetes Endocrinol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants.
Asia Sikora Kessler, T Michelle Brown, Emily Bratlee-Whitaker, Sheri Fehnel, Montserrat Vera-Llonch, Jean Bergeron

J Clin Lipidol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Course of Pregnancies and Occurrence of Acute Pancreatitis in Women with Chylomicronemia.
Miriam Larouche, Jean Bergeron, Diane Brisson, Nathalie Laflamme, Noémie Audet-Verreault

J Clin Endocrinol Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia.
Martine Paquette, Isabelle Ruel, Simon-Pierre Guay, Zobaida Al-Baldawi, Diane Brisson, Jean Bergeron

J Clin Lipidol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Statin-associated muscle symptoms : performance and quality of life].
Paul Peyrel, Pascale Mauriège, Jérôme Frenette, Jean Bergeron, Denis R Joanisse

Rev Med Suisse· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Leiter . Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine. 2024; 25: 190.
Lawrence A Leiter, Robert A Hegele, Vivien Brown, Jean Bergeron, Erin S Mackinnon

Rev Cardiovasc Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.
Paul Peyrel, Pascale Mauriège, Jérôme Frenette, Nathalie Laflamme, Karine Greffard, Jean Bergeron

J Clin Lipidol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia.
Zobaida Al-Baldawi, Leslie Brown, Isabelle Ruel, Alexis Baass, Jean Bergeron

J Clin Lipidol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Improvement in Cardiorespiratory Fitness Ameliorates Insulin Sensitivity beyond Changes in Visceral/Ectopic Fat among Men with Visceral Obesity.
Adrien Murphy-Després, Dominic J Chartrand, Isabelle Lemieux, Angelo Tremblay, Jean Bergeron

Nutrients· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease.
Lawrence A Leiter, Robert A Hegele, Vivien Brown, Jean Bergeron, Erin S Mackinnon

Rev Cardiovasc Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment.
Raul D Santos, Andrea Ruzza, Bei Wang, Paul Maruff, Adrian Schembri, Jean Bergeron

Eur J Prev Cardiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.
Milan Gupta, Rajvi J Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras

Cardiol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of statin withdrawal on perceived and objective muscle function.
Paul Peyrel, Pascale Mauriège, Jérôme Frenette, Nathalie Laflamme, Karine Greffard, Jean Bergeron

PLoS One· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous Familial Hypercholesterolemia in Canada: An Observational Study.
Leslie Brown, Isabelle Ruel, Alexis Baass, Jean Bergeron, Liam R Brunham

JACC Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial.
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron

Nat Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia.
Daniel Gaudet, Andrea Ruzza, Ian Bridges, Paul Maruff, Adrian Schembri, Jean Bergeron

J Clin Lipidol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT.
Raul D Santos, Andrea Ruzza, G Kees Hovingh, Claudia Stefanutti, François Mach, Jean Bergeron

Lancet Diabetes Endocrinol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of eruptive xanthomas associated with pregnancy unmasking a G188E heterozygous mutation of the lipoprotein lipase gene: A case report.
Caroline Paquette, Anne-Marie Careau, Jean Bergeron, Caroline Carpentier, Joël Claveau

SAGE Open Med Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study.
Milan Gupta, G B John Mancini, Rajvi J Wani, Vineeta Ahooja, Jean Bergeron

CJC Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity.
Andrée-Anne Clément, Michel Lacaille, Mohamed Amine Lounis, Laurent D Biertho, Denis Richard, Jean Bergeron

J Physiol Biochem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry.
Gabrielle Roy, Patrick Couture, Jacques Genest, Isabelle Ruel, Alexis Baass, Jean Bergeron

Can J Cardiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial.
Patrick M Moriarty, Paul D Thompson, Christopher P Cannon, John R Guyton, Jean Bergeron

J Clin Lipidol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
Raul D Santos, Andrea Ruzza, G Kees Hovingh, Albert Wiegman, François Mach, Jean Bergeron

N Engl J Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience.
Sumayah Aljenedil, Latifah Alothman, Alexandre M Bélanger, Leslie Brown, Zubin Lahijanian, Jean Bergeron

Atherosclerosis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiposity, lifestyle and vitamin D levels: the quest for answers.
Anne Gangloff, Jean Bergeron, Isabelle Lemieux, Jean-Pierre Després

Int J Obes (Lond)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis